Mutations of noncollagen genes in osteogenesis imperfecta – implications of the gene products in collagen biosynthesis and pathogenesis of disease
Journal Title: Advances in Hygiene and Experimental Medicine - Year 2012, Vol 66, Issue 0
Abstract
Recent investigations revealed that the “brittle bone” phenotype in osteogenesis imperfecta (OI) is caused not only by dominant mutations in collagen type I genes, but also by recessively inherited mutations in genes responsible for the post-translational processing of type I procollagen as well as for bone formation. The phenotype of patients with mutations in noncollagen genes overlaps with very severe type III and lethal type II OI caused by mutations in collagen genes. Mutations in genes that encode proteins involved in collagen prolyl 3-hydroxylation (P3H1/CRTAP/CyPB) eliminated Pro986 hydroxylation and caused an increase in modification of collagen helix by prolyl 4-hydroxylase and lysyl hydroxylase. However, the importance of these disturbances in the disease pathomechanism is not known. Loss of complex proteins’ function as collagen chaperones may dominate the disease mechanism. The latest findings added to the spectrum of OI-causing and collagen-influencing factors other chaperones (HSP47 and FKBP65) and protein BMP-1, which emphasizes the complexity of collagen folding and secretion as well as their importance in bone formation. Furthermore, mutations in genes encoding transcription factor SP7/Osterix and pigment epithelium-derived factor (PEDF) constitute a novel mechanism for OI, which is independent of changes in biosynthesis and processing of collagen.
Authors and Affiliations
Anna Galicka
Keywords
Related Articles
- EP ID EP66708
- DOI -
- Views 153
- Downloads 0
Mesenchymal stem cells as a therapeutic tool in tissue and organ regeneration
Tissue engineering is an interdisciplinary field that offers new opportunities for regeneration of diseased and damaged tissue with the use of many different cell types,including adult stem cells. In tissue engineering...
Biofilm Staphylococcus aureus i rola bakteriofagów w jego eradykacji
Zdolność wytwarzania biofilmu jest ważnym czynnikiem wirulencji wielu drobnoustrojów. Zakażenia z jego udziałem dotyczą prawie 65% wszystkich infekcji u ludzi. Biofilm może się rozwijać na cewnikach wewnątrznaczyniowych...
Rola limfocytów IRA B w wybranych procesach zapalnych
The first report about the discovery of new, previously unknown immune cells named IRA B cells (innate response activator B cells) appeared in 2012. So far, their presence has been verified in both mice and humans. Howev...
Peripheral blood Th17/Treg imbalance in patients with low-active systemic lupus erythematosus
Introduction: The balance between proinflammatory Th17 cells and regulatory T cells plays an important role in the pathogenesis of autoimmune diseases, including systemic lupus erythematosus (SLE). In particular, an incr...
Liposomes as non-viral carriers for genetic drugs
Methods in cancer therapy particularly in recent years, are rapidly changing, due to the need of design of new, more effective therapeutic strategies. Very promising approach to treatment of the neoplastic diseases is an...